PT Biometrik Riset Indonesia Wins Ministry of Health Tender for Bioequivalence Testing Services in 2025

PT Biometrik Riset Indonesia Wins Ministry of Health Tender for Bioequivalence Testing Services in 2025

Writer: Pandu Saputra; Editor: Rizky Puspita Dewi

Jakarta, August 22, 2025 – PT Biometrik Riset Indonesia is proud to announce its success in winning the tender from the Ministry of Health of the Republic of Indonesia (Kemenkes RI) for providing bioequivalence (BE) testing services and facilitation of the change from imported to domestic raw materials for the drugs sitagliptin, imatinib, and rivaroxaban for the 2025 fiscal year.

This renewed trust from the Ministry of Health reinforces PT Biometrik Riset Indonesia’s reputation as a reliable partner in conducting safe, effective, and high-quality generic drug testing. Previously, the company has successfully executed similar projects for the drugs amlodipine and candesartan, demonstrating our consistency and commitment to supporting national pharmaceutical resilience.

PT Biometrik Riset Indonesia’s Excellence in Bioequivalence Testing Services

Our success in securing this tender is supported by several key factors, including:

• State-of-the-art laboratory facilities that meet international standards.

• ISO 17025:2017 certification, demonstrating strict adherence to quality management systems and testing procedures.

• Experienced and professional scientific team ensuring all testing processes are accurate and timely.

• Full compliance with government regulations and health standards, ensuring the quality and safety of the tested pharmaceutical products.

• Effective project management, ensuring test results are delivered according to the agreed timeline.

Supporting Government Strategic Programs

This tender is part of the Ministry of Health’s strategic efforts to guarantee the quality, safety, and efficacy of generic medicines circulating in Indonesia. By winning this tender, PT Biometrik Riset Indonesia commits to continue providing top-quality services that contribute to the independence and resilience of the national pharmaceutical sector.

Pharmaceutical Industry Partners

Several renowned pharmaceutical companies are involved in this project, including:

• PT Sejahtera Lestari Farma

• PT Tropica Mas Pharmaceuticals

• PT Novell Pharmaceutical Laboratories

• PT Lloyd Pharma Indonesia

• PT Phapros Tbk

• PT Lapi Laboratories

• PT Bernofarm

• PT Harsen Laboratories

Our Commitment

As part of our contribution to the national health sector, PT Biometrik Riset Indonesia is committed to executing all bioequivalence testing processes with high integrity, regulatory compliance, and on-time delivery. We believe that our high-quality services will support the availability of safe and effective generic medicines for the people of Indonesia.